He Raised Drug Prices at Eli Lilly. Can He Lower Them for the U.S.?

He Raised Drug Prices at Eli Lilly. Can He Lower Them for the U.S.?-nytimes: Alex M. Azar II, President Trump’s nominee to lead the Department of Health and Human Services, has expressed concern about the soaring cost of prescription drugs for many consumers. This week, Mr. Azar, a former pharmaceutical executive, is expected to face tough questions at a Senate confirmation hearing over why his own company raised prices.